Antioxidant status, C-reactive protein and iron status in patients with pulmonary tuberculosis
- PMID: 21509257
- PMCID: PMC3074724
Antioxidant status, C-reactive protein and iron status in patients with pulmonary tuberculosis
Abstract
Objectives: The objective of this study was to evaluate the influence of acute pulmonary tuberculosis and the effect of drug therapy on markers of oxidative stress (malondialdehyde [MDA] and total antioxidant status [TAS]), C-reactive protein (CRP) and iron body status indices.
Methods: Forty patients with active pulmonary tuberculosis from the Advisory Clinic for Chest and Respiratory Diseases in Mosul City, Iraq, were included in this study, with fifty healthy age and sex matched subjects as controls. Assessment of serum concentrations of MDA, TAS, CRP, serum iron, total iron binding capacity, transferring saturation percent and ferritin were done for both patients and controls. After two months of therapy with a daily dose of isoniazid 75 mg, rifampicin 150mg, pyraziamide 400 mg, and ethambutol 275 mg, the same parameters were reassessed for the patients.
Results: After two months of therapy, there was a significant reduction in the levels of MDA, CRP, and ferritin, with a significant increase in the TAS, serum iron, and transferring saturation percentage with an insignificant effect on the total iron binding capacity in comparison with the patients' pre-therapy values.
Conclusion: Active pulmonary tuberculosis is associated with oxidative stress; the increase in the levels of CRP indicated that pulmonary tuberculosis is associated with an inflammatory response. The initial two months therapy led to significant improvement in oxidative stress and suppression of inflammatory responses. Newly diagnosed cases of pulmonary tuberculosis often had chronic anaemia of inflammation, but this therapy resulted in a significant correction of such anaemia.
Keywords: C-reactive protein; Iron status; Oxidant/antioxidant status; Pulmonary tuberculosis.
Figures



Similar articles
-
Comparative Effects of Glibenclamide and Metformin on C-Reactive Protein and Oxidant/Antioxidant Status in Patients with Type II Diabetes Mellitus.Sultan Qaboos Univ Med J. 2012 Feb;12(1):55-61. doi: 10.12816/0003088. Epub 2012 Feb 7. Sultan Qaboos Univ Med J. 2012. PMID: 22375259 Free PMC article.
-
Oxidative Stress and C-Reactive Protein in Patients with Cerebrovascular Accident (Ischaemic Stroke): The role of Ginkgo biloba extract.Sultan Qaboos Univ Med J. 2012 May;12(2):197-205. doi: 10.12816/0003113. Epub 2012 Apr 9. Sultan Qaboos Univ Med J. 2012. PMID: 22548139 Free PMC article.
-
Effect of iron supplementation on mild to moderate anaemia in pulmonary tuberculosis.Br J Nutr. 2003 Sep;90(3):541-50. doi: 10.1079/bjn2003936. Br J Nutr. 2003. PMID: 13129459 Clinical Trial.
-
Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.Cochrane Database Syst Rev. 2019 Dec 12;12(12):CD012918. doi: 10.1002/14651858.CD012918.pub2. Cochrane Database Syst Rev. 2019. PMID: 31828771 Free PMC article.
-
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].Kekkaku. 2001 Jan;76(1):33-43. Kekkaku. 2001. PMID: 11211781 Review. Japanese.
Cited by
-
Mean platelet volume as an inflammation marker in active pulmonary tuberculosis.Multidiscip Respir Med. 2014 Feb 28;9(1):11. doi: 10.1186/2049-6958-9-11. Multidiscip Respir Med. 2014. PMID: 24581084 Free PMC article.
-
A Dual Role of Heme Oxygenase-1 in Tuberculosis.Front Immunol. 2022 Feb 25;13:842858. doi: 10.3389/fimmu.2022.842858. eCollection 2022. Front Immunol. 2022. PMID: 35281042 Free PMC article. Review.
-
Modulating Iron for Metabolic Support of TB Host Defense.Front Immunol. 2018 Oct 15;9:2296. doi: 10.3389/fimmu.2018.02296. eCollection 2018. Front Immunol. 2018. PMID: 30374347 Free PMC article. Review.
-
Biomarkers of oxidative stress and personalized treatment of pulmonary tuberculosis: emerging role of gamma-glutamyltransferase.Adv Pharmacol Sci. 2012;2012:465634. doi: 10.1155/2012/465634. Epub 2012 May 7. Adv Pharmacol Sci. 2012. PMID: 22611380 Free PMC article.
-
Effects of treatment on free radicals in patients with pulmonary tuberculosis in South Western Nigeria.Afr Health Sci. 2015 Dec;15(4):1256-61. doi: 10.4314/ahs.v15i4.26. Afr Health Sci. 2015. PMID: 26958028 Free PMC article.
References
-
- Madebo T. Thesis. Centre for International Health, University of Bergen; Norway: 2003. Clinical and operational challenges in the control of tuberculosis in south Ethiopia.
-
- Jack CL, Jackson MJ, Hind CR. Circulating markers of free radical activity in patients with pulmonary tuberculosis. Tuber Lung Dis. 1994;75:132–7. - PubMed
-
- Plit ML, Theron AJ, Fickl H, Van Rensburg CE, Pendel S, Anderson R. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 1998;2:590–6. - PubMed
-
- Ribeiro MA. Levels of C-reactive protein in serum samples from healthy children and adults in São Paulo, Brazil. Braz J Med Biol Res. 1997;30:1055–9. - PubMed
-
- Baynes RD, Flex H, Bothwell TH, Bezwoda WR, Macphail AP, Alkinson P, et al. Haematological and iron related measurements in active pulmonary tuberculosis. Scand J Haematol. 1986;36:280–7. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous